Skip to main content
. 2019 Jul 25;19:163. doi: 10.1186/s12903-019-0824-3

Table 1.

Characteristics of the studies included in this meta-analysis

Author/year of publication Country Gender Mean age (Y) Intervention Follow-up (d) Study design Outcomes assessed
PRF Control
Gürbüzer/2010 [28] Turkey 7 males and 7 females 24.92 ± 4.69Y 14 14 28d RCT, split-mouth Osteoblastic activity
Eshghpour/2014 [29] Iran 33 males and 45 females 25.09 ± 4.25Y 78 78 2 and 7d RCT, split-mouth Alveolar osteitis
Baslarli/2015 [30] Turkey 7 males and 13 females 23.9Y 20 20 30 and 90d RCT, split-mouth Alveolar osteitis, osteoblastic activity
Kumar/2015 [31] India NA PRF:25.25 ± 4.2Y Control:27 ± 5.27Y 16 15 90d RCT Trismus
Ozgul/2015[32] Turkey 23 males and 33 females NA 56 56 1,3, and 7d RCT, split-mouth Pain, swelling
Uyanık/2015 [33] Cyprus 4 males, 6 females 22.65Y 10 10 1,2,3, and 7d RCT, split-mouth Pain, swelling, trismus
Bilginaylar/2016 [34] Cyprus 22 males and 37 females PRF:21.75Y Control:22.5Y 40 40 1,2,3, and 7d RCT Pain, swelling, trismus
Dutta/2016 [19] India 27 males and 13 females 27 ± 5Y 10 10 3,7, and 14d RCT Pain, swelling, soft tissue healing
Al-Hamed/2017 [16] Egypt 13 males and 34 females 25.24 ± 7.04Y 25 25 2,3,4,5,6, and 7d RCT Pain, alveolar osteitis, soft tissue healing
Gülşen/2017 [21] Turkey 21 males and 9 females 20.03Y 30 30 1,2,3, and 7d RCT, split-mouth Pain

Y years, d days, RCT randomized controlled trial, NA Not available